Literature DB >> 19917330

Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond.

Lilach O Lerman1, Stephen C Textor, Joseph P Grande.   

Abstract

Renal injury distal to an atherosclerotic renovascular obstruction reflects multiple intrinsic factors producing parenchymal tissue injury. Atherosclerotic disease pathways superimposed on renal arterial obstruction may aggravate damage to the kidney and other target organs, and some of the factors activated by renal artery stenosis may in turn accelerate the progression of atherosclerosis. This cross-talk is mediated through amplified activation of renin-angiotensin system, oxidative stress, inflammation, and fibrosis-pathways notoriously involved in renal disease progression. Oxidation of lipids also accelerates the development of fibrosis in the stenotic kidney by amplifying profibrotic mechanisms and disrupting tissue remodeling. The extent to which actual ischemia modulates injury in the stenotic kidney has been controversial, partly because the decrease in renal oxygen consumption usually parallels a decrease in renal blood flow, and because renal vein oxygen pressure in the affected kidney is not decreased. However, recent data using novel methodologies demonstrate that intra-renal oxygenation is heterogeneously affected in different regions of the kidney. Activation of such local injury within the kidney may lead to renal dysfunction and structural injury, and ultimately unfavorable and irreversible renal outcomes. Identification of specific pathways producing progressive renal injury may enable development of targeted interventions to block these pathways and preserve the stenotic kidney.

Entities:  

Mesh:

Year:  2009        PMID: 19917330      PMCID: PMC2800096          DOI: 10.1016/j.pcad.2009.09.002

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  80 in total

1.  Oxygen consumption and sodium reabsorption in the kidney.

Authors:  N A LASSEN; O MUNCK; J H THAYSEN
Journal:  Acta Physiol Scand       Date:  1961-04

2.  Effects of proteasome inhibition on the kidney in experimental hypercholesterolemia.

Authors:  Alejandro R Chade; Joerg Herrmann; Xiangyang Zhu; James D Krier; Amir Lerman; Lilach O Lerman
Journal:  J Am Soc Nephrol       Date:  2005-02-16       Impact factor: 10.121

3.  Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease.

Authors:  M Suresh; P Laboi; H Mamtora; P A Kalra
Journal:  Nephrol Dial Transplant       Date:  2000-05       Impact factor: 5.992

4.  Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK.

Authors:  C P Sodhi; D Batlle; A Sahai
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

Review 5.  Kidney in early atherosclerosis.

Authors:  Alejandro R Chade; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2005-05-16       Impact factor: 10.190

6.  Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation.

Authors:  M A Daemen; C van 't Veer; G Denecker; V H Heemskerk; T G Wolfs; M Clauss; P Vandenabeele; W A Buurman
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

7.  Long-term outcome after surgical kidney revascularization for fibromuscular dysplasia and atherosclerotic renal artery stenosis.

Authors:  Zvonimir Marekovic; Ivica Mokos; Ivan Krhen; Nedjelka Ribicic Goreta; Tomislav Roncevic
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

8.  Blood oxygen level-dependent measurement of acute intra-renal ischemia.

Authors:  Laurent Juillard; Lilach O Lerman; David G Kruger; John A Haas; Brian C Rucker; Jason A Polzin; Stephen J Riederer; Juan C Romero
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

9.  Beneficial effects of antioxidant vitamins on the stenotic kidney.

Authors:  Alejandro R Chade; Martin Rodriguez-Porcel; Joerg Herrmann; James D Krier; Xiangyang Zhu; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2003-08-18       Impact factor: 10.190

10.  Antioxidant intervention blunts renal injury in experimental renovascular disease.

Authors:  Alejandro R Chade; Martin Rodriguez-Porcel; Joerg Herrmann; Xiangyang Zhu; Joseph P Grande; Claudio Napoli; Amir Lerman; Lilach O Lerman
Journal:  J Am Soc Nephrol       Date:  2004-04       Impact factor: 10.121

View more
  57 in total

1.  Angiotensin AT₂ receptor stimulation inhibits early renal inflammation in renovascular hypertension.

Authors:  Luis C Matavelli; Jiqian Huang; Helmy M Siragy
Journal:  Hypertension       Date:  2010-12-28       Impact factor: 10.190

Review 2.  Atherosclerotic renal artery stenosis: current status.

Authors:  Soon Hyo Kwon; Lilach O Lerman
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

Review 3.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

Review 4.  Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy.

Authors:  Junjie Chen; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

5.  Obesity-metabolic derangement preserves hemodynamics but promotes intrarenal adiposity and macrophage infiltration in swine renovascular disease.

Authors:  Xin Zhang; Zi-Lun Li; John R Woollard; Alfonso Eirin; Behzad Ebrahimi; John A Crane; Xiang-Yang Zhu; Aditya S Pawar; James D Krier; Kyra L Jordan; Hui Tang; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-08

Review 6.  Blood oxygen level-dependent (BOLD) MRI in renovascular hypertension.

Authors:  Monika L Gloviczki; Lilach O Lerman; Stephen C Textor
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

7.  Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis.

Authors:  Alfonso Eirin; Xiang-Yang Zhu; Zilun Li; Behzad Ebrahimi; Xin Zhang; Hui Tang; Michael J Korsmo; Alejandro R Chade; Joseph P Grande; Christopher J Ward; Robert D Simari; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02-21       Impact factor: 8.311

8.  Effect of Huanshuai Recipe Oral Liquid ([characters: see text]) on renal dysfunction progression in patients with atherosclerotic renal artery stenosis.

Authors:  Xiu-juan Wang; Xiang-rong Rao; Shen Li; Li Wang; Chang Liu; Gai-hua Zhang; Dong-yan Han; Yu Zhao; Nan-nan Zhang; Xue-xia Li; Shuai Chen
Journal:  Chin J Integr Med       Date:  2015-04-06       Impact factor: 1.978

9.  Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis.

Authors:  Alfonso Eirin; Xin Zhang; Xiang-Yang Zhu; Hui Tang; Kyra L Jordan; Joseph P Grande; Allan B Dietz; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Nephrol Dial Transplant       Date:  2013-10-03       Impact factor: 5.992

Review 10.  Emerging Paradigms in Chronic Kidney Ischemia.

Authors:  Alfonso Eirin; Stephen C Textor; Lilach O Lerman
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.